SCHEMBL7858475

SCHEMBL7858475

Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(N)C4)c(F)c32)c(F)cc1F

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.83
▸ CYP2C9 P11712 2/20 0.83
▸ KMT2A Q03164 1/20 0.48
▸ TOP2A P11388 12/20 0.47
▸ TOP2B Q02880 10/20 0.47
▸ TOP1 P11387 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ CHRM2 P08172 1/20 0.47
▸ CHRM1 P11229 1/20 0.47
▸ OPRM1 P35372 1/20 0.47
▸ OPRD1 P41143 1/20 0.47
▸ HPGD P15428 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ EPHA2 P29317 1/20 0.45
▸ FLT4 P35916 1/20 0.45
▸ GSK3B P49841 1/20 0.45
▸ RARB P10826 1/20 0.45
▸ TBXAS1 P24557 1/20 0.45
▸ SLC6A3 Q01959 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7851011 0.93 CYP3A4 (0.80) CYP3A4CYP2C9KMT2ATOP2ATOP2B
SCHEMBL7249410 0.93 CYP3A4 (0.71) CYP3A4CYP2C9KMT2ATOP2ATOP2B
SCHEMBL7857492 0.91 CYP3A4 (0.80) CYP3A4CYP2C9KMT2ATOP2ATOP2B
SCHEMBL7851169 0.91 CYP3A4 (1.00) CYP3A4CYP2C9KMT2ATOP2ATOP2B
SCHEMBL7858514 0.90 CYP3A4 (0.68) CYP3A4CYP2C9KMT2ATOP2ATOP2B
SCHEMBL29080647 0.87 CYP3A4 (0.65) CYP3A4CYP2C9KMT2ATOP2ATOP2B
SCHEMBL30626295 0.87 CYP3A4 (0.65) CYP3A4CYP2C9KMT2ATOP2ATOP2B
SCHEMBL7851101 0.87 CYP3A4 (0.69) CYP3A4CYP2C9KMT2ATOP2ATOP2B
SCHEMBL7859695 0.86 CYP3A4 (0.68) CYP3A4CYP2C9KMT2ATOP2ATOP2B
SCHEMBL7242016 0.85 CYP3A4 (0.69) CYP3A4CYP2C9KMT2ATOP2ATOP2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0911327-B1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR THEIR SALTS AND ANTIBACTERIAL AGENT COMPRISING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMA CO LTD (JP) 2001-12-05 — — EP disclosed
US-6156903-A Pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2000-12-05 — — US disclosed
US-6133284-A EXCELLENT BACTERICIDAL PROPERTIES AND ORAL ABSORPTION; INFECTIONS FROM GRAMNEGATIVE AND -POSITIVE BACTERIA; INTESTINAL ABSORPTION, METABOLIC STABILITY; SIDE EFFECT REDUCTION; NONPHOTOTOXICITY AND NONCYTOTOXICITY WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2000-10-17 — — US disclosed
EP-0992501-A2 Pyridonecarboxylic acid derivatives as antibacterial agents WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 — — EP disclosed
US-5998436-A Pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient WAKUNAGA PHARMACEUTICALS CO., LTD. (JP) 1999-12-07 — — US disclosed
EP-0952151-A2 Intermediates for use in preparing novel pyridonecarboxylic acid derivatives or their salts WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 1999-10-27 — — EP disclosed
EP-0911327-A1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR THEIR SALTS AND ANTIBACTERIAL AGENT COMPRISING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 1999-04-28 — — EP disclosed
Send feedback